Uveitic Macular Edema

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Glenn C. Yiu, MD, PhD, of University of California, Davis, discusses suprachoroidal triamcinolone acetonide for uveitic macular edema.

In this Healio Video Perspective from the Retina Society meeting, Steven Yeh, MD, of Stanley M. Truhlsen Eye Institute, discusses Xipere for the treatment of noninfectious uveitis-associated macular edema.

PARK CITY, Utah — Suprachoroidal drug delivery for uveitic macular edema provides durable effects in real-world settings, matching those of phase 3 clinical trials, according to a speaker at Clinical Trials at the Summit.

In this Healio Video Perspective from the ASRS meeting, Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema.

The FDA approved FYB203/Ahzantive as a biosimilar to Eylea, according to a joint press release from Formycon and Klinge Biopharma.

Verana Health launched a real-world dataset for patients with uveitic macular edema, according to a press release.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Michael Singer, MD, discusses a study that investigated the durability of suprachoroidal triamcinolone acetonide for uveitic macular edema.

In this Healio Video Perspective from the Macula Society meeting, Michael A. Singer, MD, presents real-world data investigating Xipere for the treatment of uveitic macular edema.